Identification and Validation of Human Papillomavirus Encoded microRNAs

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Qian, Kui ^a   Pietilä, Tuuli ^a,b,c   Rönty, Mikko ^c   Michon, Frederic ^a   Frilander, Mikko J ^a   Ritari, Jarmo ^a   Tarkkanen, Jussi ^c   Paulín, Lars ^a   Auvinen, Petri ^a   Auvinen, Eeva ^b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MICRORNA; VIRUS RNA;

ARTICLE; CELL ADHESION; CELL CYCLE; CELL LINE; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE MAPPING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 38; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN TISSUE; IMMUNOREGULATION; IN SITU HYBRIDIZATION; MOLECULAR LIBRARY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN RNA BINDING; RNA ANALYSIS; RNA SEQUENCE; TISSUE SECTION; UTERINE CERVIX CANCER; UTERINE CERVIX DISEASE; VALIDATION PROCESS; WART VIRUS;

BASE SEQUENCE; BINDING SITES; CELL LINE; FEMALE; GENE EXPRESSION; GENOME, VIRAL; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MICRORNAS; PAPILLOMAVIRIDAE; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SEQUENCE ANALYSIS, RNA;

EID: 84880817888     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070202     Document Type: Article

References (53)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
2. Parkin DM, (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118: 3030-3044.
3. zur Hausen H, (2009) Papillomaviruses in the causation of human cancers- a brief historical account. Virology 384: 260-265.
4. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, et al. (2012) Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int J Cancer 131: 2349-2359.
5. Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF, (2009) Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog 5: e1000318.
6. Greco D, Kivi N, Qian K, Leivonen SK, Auvinen P, et al. (2011) Human papillomavirus 16 E5 modulates the expression of host microRNAs. PLoS One 6: e21646.
7. Kozomara A, Griffiths-Jones S, (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-157.
8. Grundhoff A, Sullivan CS, (2011) Virus-encoded microRNAs. Virology 411: 325-343.
9. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D, (2005) SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435: 682-686.
10. Xu N, Segerman B, Zhou X, Akusjarvi G, (2007) Adenovirus virus-associated RNAII-derived small RNAs are efficiently incorporated into the rna-induced silencing complex and associate with polyribosomes. J Virol 81: 10540-10549.
11. Hussain M, Taft RJ, Asgari S, (2008) An insect virus-encoded microRNA regulates viral replication. J Virol 82: 9164-9170.
12. Reese TA, Xia J, Johnson LS, Zhou X, Zhang W, et al. (2010) Identification of novel microRNA-like molecules generated from herpesvirus and host tRNA transcripts. J Virol 84: 10344-10353.
13. Skalsky RL, Cullen BR, (2010) Viruses, microRNAs, and host interactions. Annu Rev Microbiol 64: 123-141.
14. Cloonan N, Wani S, Xu Q, Gu J, Lea K, et al. (2011) MicroRNAs and their isomiRs function cooperatively to target common biological pathways. Genome Biol 12: R126.
15. Murphy E, Vanicek J, Robins H, Shenk T, Levine AJ, (2008) Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc Natl Acad Sci U S A 105: 5453-5458.
16. Seo GJ, Fink LH, O'Hara B, Atwood WJ, Sullivan CS, (2008) Evolutionarily conserved function of a viral microRNA. J Virol 82: 9823-9828.
17. Seo GJ, Chen CJ, Sullivan CS, (2009) Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression. Virology 383: 183-187.
18. Bauman Y, Nachmani D, Vitenshtein A, Tsukerman P, Drayman N, et al. (2011) An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe 9: 93-102.
19. Lee S, Paulson KG, Murchison EP, Afanasiev OK, Alkan C, et al. (2011) Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomas. J Clin Virol 52: 272-275.
20. Chen CJ, Kincaid RP, Seo GJ, Bennett MD, Sullivan CS, (2011) Insights into Polyomaviridae microRNA function derived from study of the bandicoot papillomatosis carcinomatosis viruses. J Virol 85: 4487-4500.
21. Cai X, Li G, Laimins LA, Cullen BR, (2006) Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication. J Virol 80: 10890-10893.
22. Lui WO, Pourmand N, Patterson BK, Fire A, (2007) Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 67: 6031-6043.
23. Gu W, An J, Ye P, Zhao KN, Antonsson A, (2011) Prediction of conserved microRNAs from skin and mucosal human papillomaviruses. Arch Virol 156: 1161-1171.
24. Dürst M, Dzarlieva-Petrusevska RT, Boukamp P, Fusenig NE, Gissmann L, (1987) Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1: 251-256.
25. Qian K, Auvinen E, Greco D, Auvinen P (2012) miRSeqNovel: An R based workflow for analyzing miRNA sequencing data. Mol Cell Probes.
26. Pattillo RA, Hussa RO, Story MT, Ruckert AC, Shalaby MR, et al. (1977) Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science 196: 1456-1458.
27. Friedl F, Kimura I, Osato T, Ito Y, (1970) Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology. Proc Soc Exp Biol Med 135: 543-545.
28. Ritari J, Hultman J, Fingerroos R, Tarkkanen J, Pullat J, et al. (2012) Detection of human papillomaviruses by polymerase chain reaction and ligation reaction on universal microarray. PLoS One 7: e34211.
29. Michon F, Tummers M, Kyyrönen M, Frilander MJ, Thesleff I, (2010) Tooth morphogenesis and ameloblast differentiation are regulated by micro-RNAs. Dev Biol 340: 355-368.
30. Witten D, Tibshirani R, Gu SG, Fire A, Lui WO, (2010) Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol 8: 58.
31. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
32. Jurak I, Kramer MF, Mellor JC, van Lint AL, Roth FP, et al. (2010) Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2. J Virol 84: 4659-4672.
33. Meng W, McElroy JP, Volinia S, Palatini J, Warner S, et al. (2013) Comparison of MicroRNA Deep Sequencing of Matched Formalin-Fixed Paraffin-Embedded and Fresh Frozen Cancer Tissues. PLoS One 8: e64393.
34. Auvinen E, Kujari H, Arstila P, Hukkanen V, (1992) Expression of the L2 and E7 genes of the human papillomavirus type 16 in female genital dysplasias. Am J Pathol 141: 1217-1224.
35. Dürst M, Glitz D, Schneider A, zur Hausen H, (1992) Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 189: 132-140.
36. Coupe VM, González-Barreiro L, Gutiérrez-Berzal J, Melián-Boveda AL, López-Rodríguez O, et al. (2012) Transcriptional analysis of human papillomavirus type 16 in histological sections of cervical dysplasia by in situ hybridisation. J Clin Pathol 65: 164-170.
37. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, et al. (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70-79.
38. Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, et al. (2006) Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 15: 1274-1280.
39. Kivi N, Greco D, Auvinen P, Auvinen E, (2008) Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression. Oncogene 27: 2532-2541.
40. Kivi N, Rönty M, Tarkkanen J, Auvinen P, Auvinen E, (2012) Cell culture model predicts human disease: Altered expression of junction proteins and matrix metalloproteinase's in cervical dysplasia. BMC Clin Pathol 12: 9.
41. Lee JH, Yi SM, Anderson ME, Berger KL, Welsh MJ, et al. (2004) Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism. Proc Natl Acad Sci U S A 101: 2094-2099.
42. Wang HK, Duffy AA, Broker TR, Chow LT, (2009) Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev 23: 181-194.
43. Kuchenbauer F, Morin RD, Argiropoulos B, Petriv OI, Griffith M, et al. (2008) In-depth characterization of the microRNA transcriptome in a leukemia progression model. Genome Res 18: 1787-1797.
44. Wang X, Tang S, Le SY, Lu R, Rader JS, et al. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557.
45. Xie H, Zhao Y, Caramuta S, Larsson C, Lui WO, (2012) miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS One 7: e46990.
46. MacLean G, Abu-Abed S, Dollé P, Tahayato A, Chambon P, et al. (2001) Cloning of a novel retinoic-acid metabolizing cytochrome P450, Cyp26B1, and comparative expression analysis with Cyp26A1 during early murine development. Mech Dev 107: 195-201.
47. Borutinskaite VV, Navakauskiene R, Magnusson KE, (2006) Retinoic acid and histone deacetylase inhibitor BML-210 inhibit proliferation of human cervical cancer HeLa cells. Ann N Y Acad Sci 1091: 346-355.
48. Darmochwal-Kolarz D, Gasowska-Giszczak U, Paduch R, Kolarz B, Wilcinski P, et al. (2009) Apoptosis of HeLa and CaSki cell lines incubated with All-trans retinoid acid. Folia Histochem Cytobiol 47: 599-603.
49. Chandrasekaran R, Thompson M, (2006) Expression, purification and characterization of individual bromodomains from human Polybromo-1. Protein Expr Purif 50: 111-117.
50. Zheng J, Saksela O, Matikainen S, Vaheri A, (1995) Keratinocyte growth factor is a bifunctional regulator of HPV16 DNA-immortalized cervical epithelial cells. J Cell Biol 129: 843-851.
51. Bernard HU, Apt D, (1994) Transcriptional control and cell type specificity of HPV gene expression. Arch Dermatol 130: 210-215.
52. Ishiji T, Lace MJ, Parkkinen S, Anderson RD, Haugen TH, et al. (1992) Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. EMBO J 11: 2271-2281.
53. Wang X, Meyers C, Wang HK, Chow LT, Zheng ZM, (2011) Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J Virol 85: 8080-8092.